ArticleClinical and molecular hepatology2024

Metformin and statins and their role in reducing hepatocellular carcinoma risk: Randomized trials are needed: Editorial on "Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy".

Paul Y KwoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.